Fluzone High Dose Northern Hemisphere Injection, Suspension
Product Images NDC 49281-125

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone High Dose Northern Hemisphere (NDC 49281-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

This is a description of an influenza vaccine called Fluzone® High-Dose, specifically formulated for individuals 65 years and older. It is a preservative-free formula for intramuscular use. The vaccine is manufactured by Sanofi Pasteur Inc.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

This text provides detailed information about an influenza vaccine with NDC number 4928146765 for the 2023-2024 season. It emphasizes storage instructions, administration method (intramuscular use), and formulation details including the presence of influenza virus strains. The vaccine is manufactured by Sanofi Pasteur Inc. and does not contain preservatives or natural rubber latex. It is also mentioned that the vaccine includes a nonionic surfactant called "Trtone X100." Users are advised to refer to the full prescribing information for additional details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.